Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0234238 (
ACHE
)
235
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To establish the chromosomal location of the human
ACHE
gene encoding the acetylcholine hydrolyzing enzyme acetylcholinesterase (
ACHE
, acetylcholine acetylhydrolase, E.C. 3.1.1.7), a human-specific polymerase chain reaction (PCR) procedure that supports the selective amplification of
ACHE
DNA fragments from human genomic DNA was employed with 19 human-hamster somatic cell hybrids carrying one or more human chromosomes. Informative
ACHE
-specific PCR fragments were produced from two cell lines, both of which include human chromosome 7, but not with DNA from 17 cell hybrids carrying various combinations of all human chromosomes other than 7. Fluorescent in situ hybridization of biotinylated
ACHE
DNA with metaphase chromosomes from human peripheral blood lymphocytes revealed prominent labeling on the 7q22 position. Therefore, further tests were performed to confirm the chromosome 7 location. DNA samples from the two cell lines including chromosome 7 and the
ACHE
gene were positive with PCR primers informative for the human
cystic fibrosis
CFTR gene, known to reside at the 7q31.1 position, but negative for the
ACHE
-related butyrylcholinesterase (BCHE, acylcholine acylhydrolase, E.C. 3.1.1.8) gene, mapped at the 3q26-ter position, confirming that these lines contain chromosome 7 but not chromosome 3. In contrast, three other cell lines including chromosome 3, but not 7, were BCHE-positive and
ACHE
-negative. In addition, genomic DNA from a sorted chromosome 7 library supported the production of
ACHE
- but not BCHE-specific PCR products, whereas with DNA from a sorted chromosome 3 library, the BCHE but not the
ACHE
fragment was amplified.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Mapping the human acetylcholinesterase gene to chromosome 7q22 by fluorescent in situ hybridization coupled with selective PCR amplification from a somatic hybrid cell panel and chromosome-sorted DNA libraries. 138 Apr 83